It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Iron overload, notably caused by hereditary hemochromatosis, is an excess storage of iron in various organs that causes tissue damage and may promote tumorigenesis. To manage that disorder, free iron depletion can be induced by iron chelators like deferoxamine that are of increasing interest also in the cancer field since iron stock could be a potent target for managing tumorigenesis. Curcumin, a well-known active substance extracted from the turmeric rhizome, destabilizes endoplasmic reticulum, and secondarily lysosomes, thereby increasing mitophagy/autophagy and subsequent apoptosis. Recent findings show that cells treated with curcumin also exhibit a decrease in ferritin, which is consistent with its chemical structure and iron chelating activity. Here we investigated how curcumin influences the intracellular effects of iron overload via Fe-nitriloacetic acid or ferric ammonium citrate loading in Huh-7 cells and explored the consequences in terms of antioxidant activity, autophagy, and apoptotic signal transduction. In experiments with T51B and RL-34 epithelial cells, we have found evidence that curcumin-iron complexation abolishes both curcumin-induced autophagy and apoptosis, together with the tumorigenic action of iron overload.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 CNRS UMR 8003, SSPIN Saints-Pères Neurosciences Institute, Paris University, Saint-Germain Campus, Paris, France; INSERM U1148, Laboratory for Vascular Translational Science, UFR SMBH, Université Paris 13, Sorbonne Paris Cité, Bobigny, France; Head of the pharmacology and toxicology department, Faculty of pharmacy Albaath university, Homs, Syria
2 CNRS UMR 8003, SSPIN Saints-Pères Neurosciences Institute, Paris University, Saint-Germain Campus, Paris, France
3 CNRS UMR 8003, SSPIN Saints-Pères Neurosciences Institute, Paris University, Saint-Germain Campus, Paris, France; Division of Molecular Medicine, Ruder Boškovic Institute, Zagreb, Croatia
4 Medical faculty Bichat, UMR 1149—ERL CNRS 8252—Université Paris Diderot Paris 7, Paris, France
5 Laboratoire Jean Perrin, Université Pierre et Marie Curie—Paris 6, CNRS FRE 3231 Case Courrier 138, Paris cedex 05, France